- Home
- FND vs ROIV Comparison
FND vs ROIV Comparison
Compare FND & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | ROIV |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 20.7B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FND | ROIV |
|---|---|---|
| Price | $57.17 | $28.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $78.81 | $27.56 |
| AVG Volume (30 Days) | 2.1M | ★ 4.7M |
| Earning Date | 05-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.05 | N/A |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $4,684,088,000.00 | $29,053,000.00 |
| Revenue This Year | $7.64 | N/A |
| Revenue Next Year | $7.70 | $385.85 |
| P/E Ratio | $29.68 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $55.11 | $8.73 |
| 52 Week High | $92.41 | $30.33 |
Technical Indicators
Market Signals| Indicator | FND | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 32.18 | 57.37 |
| Support Level | $55.11 | $26.94 |
| Resistance Level | $64.23 | N/A |
| Average True Range (ATR) | 2.52 | 1.00 |
| MACD | -0.98 | -0.23 |
| Stochastic Oscillator | 11.49 | 53.66 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.